Ignite Creation Date:
2024-05-06 @ 3:34 PM
Last Modification Date:
2024-10-26 @ 1:51 PM
Study NCT ID:
NCT04670133
Status:
WITHDRAWN
Last Update Posted:
2024-01-18
First Post:
2020-12-02
Brief Title:
Inulin Supplementation During Sanative Therapy to Further Improve Periodontal Healing
Sponsor:
Brock University
Organization:
Brock University
Study Overview
Official Title:
Intervention With Inulin to Further Support Effectiveness of Sanative Therapy Study Protocol for a Randomized Controlled Trial
Status:
WITHDRAWN
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
This study was planned before the COVID-19 pandemic and will not be pursued due to a change in research focus post-pandemic
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to investigate the effectiveness of daily supplementation with inulin before during and after sanative therapy ST on clinical outcomes of periodontal disease The study design will allow the investigators to conclude if supplementation with inulin can favourably modulate oral microbiota prior to ST and can result in better periodontal health after ST
Detailed Description:
Periodontal disease is a chronic state of inflammation that can destroy the supporting tissues around the teeth leading to a loss of connective tissue and the periodontal ligament the resorption of alveolar bone and eventual tooth loss Periodontal disease can also induce dysbiosis in the gut microbiome and contribute to low grade systemic inflammation Prebiotic fibres such as inulin can selectively alter the intestinal microbiota to bring back a state of homeostasis by improving gut barrier functions and preventing inflammation Through this mechanism supplementation with inulin may be able to indirectly benefit periodontal health The primary objective of this trial to determine if inulin supplementation provided pre-sanative therapy ST through the healing phase post-ST is more effective than the placebo at improving clinical outcomes of periodontal health decreasing both the number of sites with probing depths greater than or equal to 4 mm and increasing the absence of bleeding on probing BOP Secondary objectives include determining the effects of inulin supplementation pre- and post-ST on salivary markers of inflammation and periodontal-associated pathogens
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None